Processa Pharmaceuticals
PCSA
PCSA
11 hedge funds and large institutions have $251K invested in Processa Pharmaceuticals in 2024 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 1 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
64% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 11
Holders
11
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$115K | |
| 2 | +$54.8K | |
| 3 | +$30K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$10.5K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$426 |
Top Sellers
| 1 | -$106K | |
| 2 | -$40.8K | |
| 3 | -$25.7K | |
| 4 |
CBA
Coastal Bridge Advisors
Westport,
Connecticut
|
-$21.7K |
| 5 |
Renaissance Technologies
New York
|
-$19K |